Home › Compare › BBRDF vs MRK

BBRDF vs MRK: Dividend Comparison 2026

BBRDF yields 6250.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BBRDF wins by $547038161900822.19M in total portfolio value
10 years
BBRDF
BBRDF
● Live price
6250.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$547038161900822.19M
Annual income
$530,345,833,482,145,900,000.00
Full BBRDF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — BBRDF vs MRK

📍 BBRDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBBRDFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BBRDF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BBRDF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BBRDF
Annual income on $10K today (after 15% tax)
$531,250.00/yr
After 10yr DRIP, annual income (after tax)
$450,793,958,459,824,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, BBRDF beats the other by $450,793,958,459,824,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BBRDF + MRK for your $10,000?

BBRDF: 50%MRK: 50%
100% MRK50/50100% BBRDF
Portfolio after 10yr
$273519080950411.09M
Annual income
$265,172,916,741,072,950,000.00/yr
Blended yield
96.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BBRDF
No analyst data
Altman Z
1.4
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BBRDF buys
0
MRK buys
0
No recent congressional trades found for BBRDF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBBRDFMRK
Forward yield6250.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$547038161900822.19M ✓$30.7K
Annual income after 10y$530,345,833,482,145,900,000.00 ✓$950.29
Total dividends collected$545916230838674.88M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BBRDF vs MRK ($10,000, DRIP)

YearBBRDF PortfolioBBRDF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$635,700$625,000.00$11,192$351.54+$624.5K → BBRDF
2$37,812,208$37,132,009.35$12,524$392.70+$37.80M → BBRDF
3$2,104,624,511$2,064,165,448.17$14,015$438.65+$2104.61M → BBRDF
4$109,626,980,731$107,375,032,504.06$15,682$489.96+$109626.97M → BBRDF
5$5,344,419,538,811$5,227,118,669,428.94$17,547$547.23+$5344419.52M → BBRDF
6$243,874,608,189,950$238,156,079,283,422.40$19,632$611.16+$243874608.17M → BBRDF
7$10,417,442,627,867,752$10,156,496,797,104,504.00$21,963$682.53+$10417442627.85M → BBRDF
8$416,612,895,336,954,560$405,466,231,725,136,060.00$24,571$762.18+$416612895336.93M → BBRDF
9$15,600,306,933,342,350,000$15,154,531,135,331,807,000.00$27,486$851.08+$15600306933342.32M → BBRDF
10$547,038,161,900,822,200,000$530,345,833,482,145,900,000.00$30,745$950.29+$547038161900822.19M → BBRDF

BBRDF vs MRK: Complete Analysis 2026

BBRDF — Stock

Blackbird plc develops and operates a cloud-based video editing and publishing platform under the Blackbird name in the United Kingdom, rest of Europe, North America, and internationally. The company's platform is used for video viewing, editing, and publishing. It serves news, sports, entertainment, and other sectors. The company was formerly known as Forbidden Technologies plc and changed its name to Blackbird plc in May 2019. Blackbird plc was incorporated in 1998 and is based in London, the United Kingdom.

Full BBRDF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this BBRDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BBRDF vs SCHDBBRDF vs JEPIBBRDF vs OBBRDF vs KOBBRDF vs MAINBBRDF vs JNJBBRDF vs ABBVBBRDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.